Hiromi Ishibashi mainly focuses on Immunology, Primary biliary cirrhosis, Internal medicine, Endocrinology and Gastroenterology. His study ties his expertise on Peripheral blood mononuclear cell together with the subject of Immunology. Hiromi Ishibashi has researched Primary biliary cirrhosis in several fields, including Liver transplantation, T cell, Autoantibody, Antibody and Ursodeoxycholic acid.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Viral disease. His studies in Endocrinology integrate themes in fields like Growth factor, Lung, Respiratory system and Liver regeneration. His Gastroenterology study combines topics in areas such as Combination therapy and Risk factor.
His primary areas of study are Internal medicine, Gastroenterology, Immunology, Primary biliary cirrhosis and Pathology. His study in Endocrinology extends to Internal medicine with its themes. The study incorporates disciplines such as Kupffer cell, Molecular biology and Cytokine in addition to Endocrinology.
His Gastroenterology research is multidisciplinary, incorporating elements of Chronic hepatitis, Liver transplantation and Hepatitis C virus. His Immunology and Antigen, Immune system, Autoimmune disease, Autoimmune hepatitis and Antigen-presenting cell investigations all form part of his Immunology research activities. Hiromi Ishibashi has included themes like Epitope, Autoantibody, Antibody, Ursodeoxycholic acid and T cell in his Primary biliary cirrhosis study.
Internal medicine, Gastroenterology, Primary biliary cirrhosis, Immunology and Hepatocellular carcinoma are his primary areas of study. His Internal medicine study deals with Endocrinology intersecting with Cytokine. His biological study spans a wide range of topics, including Odds ratio, Pathology, Autoimmune hepatitis and Univariate analysis.
His research investigates the connection between Primary biliary cirrhosis and topics such as Single-nucleotide polymorphism that intersect with issues in Haplotype. In his study, Allele is inextricably linked to Genetic predisposition, which falls within the broad field of Immunology. Within one scientific family, Hiromi Ishibashi focuses on topics pertaining to Carcinoma under Hepatocellular carcinoma, and may sometimes address concerns connected to Alpha-fetoprotein.
Hiromi Ishibashi mainly investigates Primary biliary cirrhosis, Immunology, Internal medicine, Gastroenterology and Hepatitis. The various areas that Hiromi Ishibashi examines in his Primary biliary cirrhosis study include Hepatobiliary disease, Cytokine, Anti-nuclear antibody, Autoantibody and Intensive care medicine. His Immunology research includes themes of Odds ratio, Single-nucleotide polymorphism and Haplotype.
His study focuses on the intersection of Internal medicine and fields such as Serology with connections in the field of B-cell activating factor, Bilirubin, Blood serum and Endocrinology. Many of his studies on Gastroenterology apply to Tumor necrosis factor alpha as well. Hiromi Ishibashi interconnects Inflammation, Liver function and Pathology in the investigation of issues within Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆
Carlo F Selmi;Carlo F Selmi;Marlyn J. Mayo;Nancy Bach;Hiromi Ishibashi.
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.
Shinji Shimoda;Minoru Nakamura;Hiromi Ishibashi;Kazuhiro Hayashida.
Journal of Experimental Medicine (1995)
Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
Minoru Nakamura;Hisayoshi Kondo;Tsuyoshi Mori;Atsumasa Komori.
Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs.
Kimihiko Yanagita;Mika Nagaike;Hiromi Ishibashi;Yoshiyuki Niho.
Biochemical and Biophysical Research Communications (1992)
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.
Shinji Shimoda;Shinji Shimoda;Judith A Van de Water;Aftab Ansari;Minoru Nakamura.
Journal of Clinical Investigation (1998)
Consumption of wild boar linked to cases of hepatitis E.
Yoko Tamada;Koji Yano;Hiroshi Yatsuhashi;Osami Inoue.
Journal of Hepatology (2004)
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.
Minoru Nakamura;Nao Nishida;Minae Kawashima;Yoshihiro Aiba.
American Journal of Human Genetics (2012)
Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.
Hideyuki Nomura;Suketo Sou;Hironori Tanimoto;Takashi Nagahama.
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
Seigo Abiru;Kiyoshi Migita;Yumi Maeda;Manabu Daikoku.
Liver International (2006)
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
H Yoshida;R Tateishi;Y Arakawa;M Sata.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: